Where does THE Scripps Research Institute rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), THE Scripps Research Institute ranks #1,077 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does THE Scripps Research Institute hold?

THE Scripps Research Institute holds 400 US utility patents granted between 2015 and 2025, spanning 40 technology areas.

What is THE Scripps Research Institute's Innovation Score?

THE Scripps Research Institute has an Innovation Score of 55.6 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does THE Scripps Research Institute focus on?

THE Scripps Research Institute's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 231 patents, ranking #53 of 6,058 assignees active in that subclass. Grants appear in 40 CPC subclasses total.

Is THE Scripps Research Institute's patent grant rate increasing or decreasing?

THE Scripps Research Institute's recent grant velocity is -14% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for THE Scripps Research Institute's patents?

THE Scripps Research Institute's patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the THE Scripps Research Institute patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

THE Scripps Research Institute

USPTO PatentsView assignee record - 400 granted patents across 40 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, THE ranks #1,077 of 49,997 tracked US assignees by granted-patent volume, with 400 patents across 40 technology areas.

#1,077
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.6/100): 15.2
avg claims per patent: -14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1077 · US Corporation #1,077 · 400 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 400 grants
TOP-DECILE #1,077/49,997
PHOTO-FINISH Electrolux Home…
CPC-WIDE A61P · 40 areas
INNOV-PAR 55.6/100
CLAIMS-RICH 15.2 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Electrolux Home Products, Inc. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How THE’s 55.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.7 pts (37%) Velocity 3.4 pts (6%) Breadth 22.4 pts (40%) Claim depth 9.1 pts (16%)

Qualcomm Incorporated · highest

85
AMP Robotics · near

56
Armada Systems · near

56
Lapis Semiconductor · near

56
Oki Data · near

56
THE Scripps… · this assignee

56
3D Lighting… · lowest

7

What this shows THE's Innovation Score is 55.6/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for THE?

Each dot is one of THE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). THE’s own 15.2 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

THE vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where THE's grants concentrate

THE Scripps Research Institute is a focused PatentsView assignee: 40 CPC subclasses with 57.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (58 grants) versus a trough of 19 in 2024. By volume, THE sits between Dow Silicones Corporation and Digital Global Systems, Inc..

THE's three-year grant acceleration

From 2019–2021 to 2022–2024, THE Scripps Research Institute moved from 143 to 74 grants (0.52x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,643. See the growth leaderboard.

Dow Silicones

402
Electrolux Home P…

401
Fisher-rosemount…

401
Ubtech Robotics

401
THE Scripps Resea… ◀

400
Indiana Universit…

399
Mstar Semiconduct…

399
Solaredge

399
Digital Global Sy…

396

What this shows THE holds 400 patents at rank #1,077, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #1,077 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in THE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for THE, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), THE ranks #53 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (56 here).

Lapis Semiconductor Co., Ltd. 56 Oki Data Corporation 56 AMP Robotics Corporation 56 Armada Systems Inc. 56

Similar claim depth

Nearest assignees by average claims per patent (15.2 here).

Bayer Healthcare LLC 15.2 avg Leidos, Inc. 15.2 avg Hanmi Pharm. Co., Ltd. 15.2 avg Samson Aktiengesellschaft 15.2 avg

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

THE Scripps Research Institute patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	37	9.3%
2016	26	6.5%
2017	56	14.0%
2018	41	10.3%
2019	43	10.8%
2020	58	14.5%
2021	42	10.5%
2022	30	7.5%
2023	25	6.3%
2024	19	4.8%
2025partial year	23	5.8%

Which technologies does THE Scripps Research Institute patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 231

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 227

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 140

C07D - Heterocyclic Compounds 135

C07K - Peptides 134

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 48

C07C - Acyclic OR Carbocyclic Compounds 48

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 26

C12Y - Enzymes 20

Y02A - Technologies FOR Adaptation TO Climate Change 20

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 15

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 15

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 15

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 14

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 13

Top 15 of 40 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

THE Scripps Research Institute's patent record in context - here's where to go next.

THE Scripps Research Institute's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 57.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #1,077 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare THE Scripps Research Institute against Dow Silicones Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.